SEC Tracker
Get the app

Bolt Biotherapeutics BOLT

Bolt Biotherapeutics acquires Prana Therapies

Item 1.01 Enters material agreement, Item 1.02 Ends material agreement, Item 2.01 Completes acquisition or sale

Form
8-K
Filed
Importance
Major
  1. Bolt acquired Prana on Oct 23, 2026
  2. Bolt issued 430,746 shares of common stock to Prana shareholders
  3. Bolt issued 16,360.929 shares of Series D Preferred Stock to Prana shareholders
  4. Series D Preferred Stock is convertible into 1,000 shares of common stock

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Bolt Biotherapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Intensity Therapeutics INTS public float $7M, Jun 30, 2025
  2. Zeo ScientifiX ZEOX public float $7M, Apr 30, 2025, over 18 months old
  3. Genprex GNPX public float $8M, Jun 30, 2025
  4. VivoSim Labs VIVS public float $8M, Sep 30, 2025
  5. Sunshine Biopharma SBFM public float $7M, Jun 30, 2025